Press Releases
New study into Tuberculosis membrane molecules will aid drug delivery
A new method to aid in the development of antibiotics for tuberculosis (TB) infections has been devised.
£1.7m memorial donation enables new antimicrobial research
A £1.7 million memorial donation will help drive new research into antimicrobial resistance at the University of Warwick.
Cancer origin identified through cell ‘surgery’ – new research
Research from the University of Warwick sheds new light on a key cause of cancer formation during cell division (or mitosis), and points towards potential solutions for preventing it from occurring.
Cell couriers deliver clue to cancer metastasis
A protein involved in making cells move offers a clue to how certain types of cancer metastasize and develop into secondary tumours, according to new research from the University of Warwick.
Construction completed on “world-class” IBRB biomedical research building at the University of Warwick
NATIONAL contractor, Willmott Dixon has completed the construction of the Interdisciplinary Biomedical Research Building at the University of Warwick this month (March 2021).
Understanding lung infections in patients with cystic fibrosis
For young people with cystic fibrosis, lung infection with Staphylococcus aureus, MRSA, is common and is treated with antibiotics in the hope that this will prevent a decline in lung function. However there has recently been debate over the role S. aureus plays in CF lung disease. Researchers from the University of Warwick have used a new model of CF lungs which could be used to make better decisions about future use of antibiotics.